GHK-Cu · Clinical molecule review
Clinic Terrain reviews GHK-Cu molecule by molecule, identity, mechanism, human evidence, individual fit and the verification required before any protocol could be proposed.
For people asking whether GHK-Cu is relevant to a defined objective, not looking for an unverified vial or an automatic protocol.Request a GHK-Cu review →
Scientific dossier
The scientific page treats identity, target architecture, signalling, pharmacology, physiology, counterevidence and falsification independently from the service offer.
GHK-Cu is the copper complex of glycyl-L-histidyl-L-lysine. Free GHK, copper ions and the coordinated GHK-Cu complex are related but not identical experimental entities; topical evidence does not automatically support systemic use.
The relevant causal architecture is copper transport, extracellular-matrix signalling and tissue-remodelling biology. Matrix signalling and copper coordination are real chemistry; they do not prove that every formulation reaches the tissue or produces a clinically favourable remodelling response.
The review identifies skin, hair, wound or deeper tissue objectives, exact formulation and route, copper status where relevant, liver context, medication and the need for conventional diagnosis.
Clinical relevance is only the first gate. A proposed route would also require a lawful pathway, current availability, exact formulation and presentation, responsible source, current lot, matching analytical documentation, receipt and storage controls. Clinic Terrain does not infer those facts from the molecule name or from a monograph.
Photography, lesion or scar dimensions, validated skin or hair measures, symptoms and tolerability are selected according to the tissue rather than grouped under ‘regeneration’. Continue, refine and stop decisions remain attached to the physician-reviewed record.
Direct answers
Yes. The clinical team can review the molecule, evidence and individual question. Assessment does not promise that a product is indicated, lawfully available, verified or supplied. GHK-Cu access begins by separating skin, hair, wound and deeper-tissue questions, then resolving copper coordination, formulation and route. Topical data cannot automatically support systemic administration.
No current product price is published for GHK-Cu. A commercial quote would be inappropriate before the lawful route, exact presentation, current availability and matching product documentation are resolved.
Matrix signalling and copper coordination are real chemistry; they do not prove that every formulation reaches the tissue or produces a clinically favourable remodelling response.
Photography, lesion or scar dimensions, validated skin or hair measures, symptoms and tolerability are selected according to the tissue rather than grouped under ‘regeneration’.
Evidence position
Sources used for this page
Primary sourcePickart et al. Biomed Res Int. 2015;2015:648108. ↗GHK is glycyl-L-histidyl-L-lysine; GHK-Cu is its Cu(II) complex.Primary sourceWegrowski et al. GHK-Cu stimulates sulfated glycosaminoglycan synthesis. Life Sci. 1992. ↗The mechanistic programme includes copper binding, extracellular-matrix regulation, fibroblast collagen synthesis, wound biology and gene-expression effects under defined experimental conditions.Primary sourceZhang et al. Synergy of GHK-Cu and hyaluronic acid on collagen IV in fibroblast and ex-vivo skin tests. J Cosmet Dermatol. 2023. ↗Topical cosmetic literature reports signals but products vary.Regulatory guidanceWHO: good storage and distribution practices for medical products ↗This guidance defines supply-chain controls only. It does not prove the identity, purity, sterility or suitability of a specific product or lot.Primary sourceKang et al. Copper-GHK increases integrin expression and p63 positivity in keratinocytes. Arch Dermatol Res. 2009. ↗The controlled topical result constrains the leap from fibroblast biology to guaranteed visible rejuvenation.Regulatory guidanceICH: harmonised pharmaceutical quality guidelines ↗This framework explains what a quality system must establish. It is not analytical evidence for a Clinic Terrain product or lot.Your first message · Where you are + what you need help with